Belsky Marc

CIK 00013826293 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001382629

Recent Transactions

50 trades

Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2025-03-27+4,800→ 12,000 total
Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2025-03-04+7,200→ 7,200 total
Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2025-01-09+24,500→ 24,500 total
Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2024-01-07+295,000→ 295,000 total
Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2023-07-24+140,000→ 140,000 total
Disposition to Issuer
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2023-07-24−60,000→ 0 total
Disposition to Issuer
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2023-07-24−90,000→ 0 total
Disposition to Issuer
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2023-07-24−220,000→ 0 total
Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2023-07-24+90,000→ 90,000 total
Disposition to Issuer
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2023-07-24−140,000→ 0 total
Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2023-07-24+195,000→ 195,000 total
Disposition to Issuer
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2023-07-24−60,000→ 0 total
Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2023-07-24+60,000→ 60,000 total
Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2023-07-24+60,000→ 60,000 total
Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2023-07-24+220,000→ 220,000 total
Disposition to Issuer
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2023-07-24−195,000→ 0 total
Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2023-01-08+195,000→ 195,000 total
Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2022-01-05+140,000→ 140,000 total
Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2021-01-08+220,000→ 220,000 total
Purchase
Kezar Life Sciences, Inc.$KZR
Common Stock
2020-02-04$2.60/sh+15,384→ 15,384 total
Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2020-01-12+90,000→ 90,000 total
Purchase
Kezar Life Sciences, Inc.$KZR
Common Stock
2019-11-13$2.76/sh+800→ 2,000 total
Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2019-09-06+60,000→ 60,000 total
Purchase
Kezar Life Sciences, Inc.$KZR
Common Stock
2019-08-20$4.42/sh+200→ 1,200 total
Purchase
Kezar Life Sciences, Inc.$KZR
Common Stock
2019-08-09$4.82/sh+500→ 1,000 total
Purchase
Kezar Life Sciences, Inc.$KZR
Common Stock
2019-07-26$5.80/sh+56→ 500 total
Purchase
Kezar Life Sciences, Inc.$KZR
Common Stock
2019-07-25$5.65/sh+444→ 444 total
Award
Kezar Life Sciences, Inc.$KZR
Employee Stock Option (right to buy)
2019-01-06+60,000→ 60,000 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2018-02-26+18,000→ 18,000 total
Award
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2018-02-26+3,000→ 16,314 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2018-02-05$18.42/sh−1,048→ 13,314 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2017-09-01$34.34/sh−921→ 16,982 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2017-03-01$44.77/sh−18,881→ 46,785 total
Award
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2017-02-07+7,031→ 12,656 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2017-02-07+22,500→ 22,500 total
Award
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2017-02-07+5,625→ 5,625 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2017-01-03$48.60/sh−2,281→ 65,666 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-09-01$44.74/sh+17,980→ 67,947 total
Award
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-08-25+5,000→ 85,927 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2016-08-25+30,000→ 30,000 total
Sale
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-04-22$50.03/sh−33,002→ 80,927 total
Sale
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-04-22$49.24/sh−1,100→ 113,929 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2016-04-22−12,389→ 17,611 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-04-22$5.54/sh+7,483→ 88,410 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2016-04-22−7,483→ 509 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2016-04-22−11,178→ 5,082 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2016-04-22−3,052→ 41,948 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-04-22$7.26/sh+11,178→ 99,588 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-04-22$19.25/sh+3,052→ 115,029 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2016-04-22$11.14/sh+12,389→ 111,977 total

Companies

Recent Filings

Address

CELL GENESYS, INC. 500 FORBES BLVD.

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov